---
figid: PMC7676935__BMRI2020-3828249.002
figtitle: Summary of the possible signaling pathway between gut microbiota-bile acids
  axis and IBS-D
organisms:
- Escherichia coli
- Staphylococcus aureus
- Pseudomonas aeruginosa
- Listeria monocytogenes
- Enterococcus faecalis
- Lactococcus lactis
- Bacteroides fragilis
- Clostridium perfringens
- Escherichia coli O157H7
- Akkermansia muciniphila
- Streptococcus thermophilus
- Lacticaseibacillus paracasei
- Bifidobacterium animalis subsp. lactis
- Escherichia coli Nissle 1917
- Phocaeicola vulgatus
- Ligilactobacillus salivarius
- Weizmannia coagulans
- Lactobacillus johnsonii
- Clostridium scindens
- Lactobacillus acidophilus NCFM
- Methanobrevibacter smithii
- Lactococcus plantarum
- Peptacetobacter hiranonis
- Paeniclostridium sordellii
- Bifidobacterium longum subsp. longum
- Clostridium hylemonae
- Peptostreptococcaceae
- Mus musculus
- Rattus norvegicus
- Bletilla striata
- Berberis heteropoda
- Homo sapiens
- gut metagenome
- unidentified
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC7676935
filename: BMRI2020-3828249.002.jpg
figlink: pmc/articles/PMC7676935/figure/fig2/
number: F2
caption: 'Summary of the possible signaling pathway between gut microbiota-bile acids
  axis and IBS-D. The metabolic disorder of the gut microbiota-bile acid axis could
  lead to the higher secretion levels of secondary BAs, which activate a series of
  signaling pathways in the intestinal epithelium, resulting in VH, damage of intestinal
  mucosal barrier function, increased intestinal motility, and increased intestinal
  bile acid excretion, thus promoting the occurrence of IBS-D. On the one hand, the
  reduced expression of FXR can not only upregulate the NGF/TRPV1 signaling pathway
  to cause VH but also downregulate FGF19/15 that can regulate the JNK1/2 and ERK1/2
  signaling pathway to make an inhibition on intestinal barrier function and promote
  autophagy. On the other hand, the increased secondary BAs can activate TGR5 on EC
  cells to up-regulate the expression of 5–HT and CGRP, causing increased colonic
  motility. At the same time, 5-HT could upregulate the release of 5-HT3R to cause
  VH and transmit stimulus to the spinal cord, the process of which may be involved
  in the brain-gut interaction. Abbreviations: BAs: bile acids; FXR: farnesoid X receptor;
  NGF: nerve growth factor; TRPV1: transient receptor potential vanilloid 1; VH: visceral
  hypersensitivity; FGF19/15: fibroblast growth factor (FGF) 19/15; JNK: c-Jun N-terminal
  kinase; ERK: extracellular signal-regulated kinase; TJ: tight junction; CYP7A1:
  cholesterol 7α-hydroxylase; SHP: small heterodimer partner; TGR5: G-protein-coupled
  bile acid receptor 1; 5-HT: 5-hydroxytryptamine; 5-HT3R: 5-hydroxytryptamine 3 receptor;
  CGRP: calcitonin gene-related peptide; EC: enterochromaffin; SCFA: short-chain fatty
  acids; ENS: enteric nervous system; CNS: central nervous system; VDR: vitamin D
  receptor.'
papertitle: Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome.
reftext: Kai Zhan, et al. Biomed Res Int. 2020;2020:3828249.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9489962
figid_alias: PMC7676935__F2
figtype: Figure
redirect_from: /figures/PMC7676935__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7676935__BMRI2020-3828249.002.html
  '@type': Dataset
  description: 'Summary of the possible signaling pathway between gut microbiota-bile
    acids axis and IBS-D. The metabolic disorder of the gut microbiota-bile acid axis
    could lead to the higher secretion levels of secondary BAs, which activate a series
    of signaling pathways in the intestinal epithelium, resulting in VH, damage of
    intestinal mucosal barrier function, increased intestinal motility, and increased
    intestinal bile acid excretion, thus promoting the occurrence of IBS-D. On the
    one hand, the reduced expression of FXR can not only upregulate the NGF/TRPV1
    signaling pathway to cause VH but also downregulate FGF19/15 that can regulate
    the JNK1/2 and ERK1/2 signaling pathway to make an inhibition on intestinal barrier
    function and promote autophagy. On the other hand, the increased secondary BAs
    can activate TGR5 on EC cells to up-regulate the expression of 5–HT and CGRP,
    causing increased colonic motility. At the same time, 5-HT could upregulate the
    release of 5-HT3R to cause VH and transmit stimulus to the spinal cord, the process
    of which may be involved in the brain-gut interaction. Abbreviations: BAs: bile
    acids; FXR: farnesoid X receptor; NGF: nerve growth factor; TRPV1: transient receptor
    potential vanilloid 1; VH: visceral hypersensitivity; FGF19/15: fibroblast growth
    factor (FGF) 19/15; JNK: c-Jun N-terminal kinase; ERK: extracellular signal-regulated
    kinase; TJ: tight junction; CYP7A1: cholesterol 7α-hydroxylase; SHP: small heterodimer
    partner; TGR5: G-protein-coupled bile acid receptor 1; 5-HT: 5-hydroxytryptamine;
    5-HT3R: 5-hydroxytryptamine 3 receptor; CGRP: calcitonin gene-related peptide;
    EC: enterochromaffin; SCFA: short-chain fatty acids; ENS: enteric nervous system;
    CNS: central nervous system; VDR: vitamin D receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Gusb
  - Bas
  - Nr1h4
  - Vdr
  - Cyp27b1
  - Fgf15
  - Ngf
  - Mapk3
  - Ephb2
  - Mapk1
  - Nr0b2
  - Htr3a
  - Ie
  - BAS
  - NR1H4
  - VDR
  - CYP27B1
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - NGF
  - MAPK3
  - EPHB2
  - MAPK1
  - NR0B2
  - HTR3A
  - Fgf19
  - Ephb1
  - bas
  - para
  - pyd3
  - gprs
  - ec
  - Fmr1
  - fzr
  - bnl
  - rl
  - Erk7
  - shp
  - ens
---
